Table 2 Multivariable analysis (Cox proportional hazard model) of OS for HR+ MBC
From: Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry
N = 832 (events 525) | HR | 95% CI | P |
|---|---|---|---|
Age (continuous) according to menopausal status | |||
Premenopausal | 1.04 | 1.03–1.06 |  < 0.001 |
Postmenopausal | 1.03 | 1.02–1.04 |  < 0.001 |
DFS | |||
 ≥ 24 months or de novo versus < 24 months | 0.75 | 0.59–0.95 | 0.017 |
Visceral versus no visceral disease* | 1.26 | 1.02–1.55 | 0.030 |
Number of metastatic sites* | |||
2–3 versus 1 | 1.25 | 1.02–1.53 | 0.029 |
 ≥ 4 versus 1 | 1.73 | 1.16–2.59 | 0.007 |
HER2-low versus HER2-0 | 0.89 | 0.74–1.05 | 0.171 |